Reclazepam
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DePiep (talk | contribs) at 20:28, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H13Cl2N3O2 |
| Molar mass | 374.221 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]
See also
References
- ^ US Patent 4208327
- ^ Pscyhotropics.dk (20 January 1986). "reclazepam". Retrieved 24 August 2009.
